Average Co-Inventor Count = 6.39
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (12 from 3,224 patents)
2. Ventana Medical Systems, Inc. (2 from 516 patents)
3. Genetech, Inc. (2 from 98 patents)
4. Spring Bioscience Corporation (1 from 6 patents)
5. F. Hoffmann-La Roche Ag (168 patents)
16 patents:
1. 11530269 - Anti-PD-L1 antibodies and diagnostic uses thereof
2. 11299544 - Biomarkers and methods of treating PD-1 and PD-L1 related conditions
3. 10689445 - Anti-PD-L1 antibodies and diagnostic uses thereof
4. 10240207 - Cancer treatment with c-met antagonists and correlation of the latter with HGF expression
5. 8993249 - Anti-neuropilin antibodies and methods of use
6. 8728480 - Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof
7. 8388973 - Compositions and methods for the treatment of tumor of hematopoietic origin
8. 8278042 - Compositions and methods for the diagnosis and treatment of tumor
9. 7888478 - Compositions and methods for the treatment of tumor of hematopoietic origin
10. 7858330 - Compositions and methods for the treatment of tumor of hematopoietic origin
11. 7803915 - Antibody compositions for the diagnosis and treatment of tumor
12. 7749504 - Anti-TAT188 antibodies
13. 7435416 - Anti-tumor antibody compositions and methods of use
14. 7390882 - Compositions and methods for the diagnosis and treatment of tumor
15. 6824780 - Anti-tumor antibody compositions and methods of use